@entity5646 versus @entity801 , each with XXXX , in the treatment of @entity7288 .

@entity1 @entity801 @entity7288 @entity294 @entity56 @entity2259 @entity5646 @entity3402
A randomized comparison of @entity5646 (2 g intravenously every eight hours) versus @entity801 (1.5 mg/kg intravenously every eight hours), each with @entity3402 (600 mg intravenously every six hours), was performed in 119 @entity1 with @entity7288 after cesarean section. @entity1 in both groups had similar risk factors. Genital cultures revealed an average of 3.0 isolates per specimen. Eighty-five aerobic gram-negative rods were isolated from 57 (48%) @entity1 . All were susceptible to both @entity5646 and @entity801 . Of 133 anaerobic isolates, 131 (98%) were susceptible to @entity3402 . The failures in the @entity5646 group were associated with a wound abscess and with an @entity2259 . Of the six failures in the @entity801 group, two were associated with persistent isolation of enteric bacilli. In the other four failures, no explanation was evident. Side effects occurred in four @entity1 , (three @entity294 , one @entity56 ). All were self-limited and appeared to be due to @entity3402 . No @entity1 showed nephrotoxicity. When used in combination with @entity3402 , @entity5646 gave clinical results similar to @entity801 .
